Nugen Medical Devices Stock Analysis
| NGMDF Stock | USD 0.02 0.0003 1.20% |
NuGen Medical Devices has over 5.61 Million in debt which may indicate that it relies heavily on debt financing. NuGen Medical's financial risk is the risk to NuGen Medical stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
NuGen Medical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. NuGen Medical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the OTC Stock is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps NuGen OTC Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect NuGen Medical's stakeholders.
For most companies, including NuGen Medical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for NuGen Medical Devices, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, NuGen Medical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that NuGen Medical's debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which NuGen Medical is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of NuGen Medical to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, NuGen Medical is said to be less leveraged. If creditors hold a majority of NuGen Medical's assets, the OTC Stock is said to be highly leveraged.
NuGen Medical Devices is overvalued with Real Value of 0.0218 and Hype Value of 0.02. The main objective of NuGen Medical otc analysis is to determine its intrinsic value, which is an estimate of what NuGen Medical Devices is worth, separate from its market price. There are two main types of NuGen Medical's stock analysis: fundamental analysis and technical analysis.
The NuGen Medical otc stock is traded in the USA on OTCQB Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and NuGen Medical's ongoing operational relationships across important fundamental and technical indicators.
NuGen |
NuGen OTC Stock Analysis Notes
About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.08. NuGen Medical Devices had not issued any dividends in recent years. NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventionalpediatric vaccines. Nugen Med operates under Medical Devices classification in the United States and is traded on OTC Exchange.The quote for NuGen Medical Devices is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about NuGen Medical Devices contact Michael Wright at 833 285 2666 or learn more at https://www.nugenmd.com.NuGen Medical Devices Investment Alerts
| NuGen Medical generated a negative expected return over the last 90 days | |
| NuGen Medical has some characteristics of a very speculative penny stock | |
| NuGen Medical has high likelihood to experience some financial distress in the next 2 years | |
| NuGen Medical Devices has accumulated 5.61 M in total debt with debt to equity ratio (D/E) of 7.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. NuGen Medical Devices has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist NuGen Medical until it has trouble settling it off, either with new capital or with free cash flow. So, NuGen Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NuGen Medical Devices sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NuGen to invest in growth at high rates of return. When we think about NuGen Medical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 137.65 K. Net Loss for the year was (7.11 M) with profit before overhead, payroll, taxes, and interest of 47.3 K. | |
| NuGen Medical Devices has accumulated about 87.48 K in cash with (4.1 M) of positive cash flow from operations. | |
| Roughly 19.0% of NuGen Medical outstanding shares are owned by corporate insiders |
NuGen Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NuGen Medical's market, we take the total number of its shares issued and multiply it by NuGen Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 30th of January, NuGen Medical secures the risk adjusted performance of (0.15), and Mean Deviation of 0.8857. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NuGen Medical Devices, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to break down twelve technical drivers for NuGen Medical, which can be compared to its peers in the industry. Please verify NuGen Medical Devices coefficient of variation, total risk alpha, as well as the relationship between the Total Risk Alpha and value at risk to decide if NuGen Medical Devices is priced some-what accurately, providing market reflects its recent price of 0.0247 per share. As NuGen Medical Devices appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.NuGen Medical Devices Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. NuGen Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for NuGen Medical Devices. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
NuGen Medical Predictive Daily Indicators
NuGen Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NuGen Medical otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 0.0247 | |||
| Day Typical Price | 0.0247 | |||
| Price Action Indicator | (0.0001) | |||
| Period Momentum Indicator | (0.0003) |
NuGen Medical Forecast Models
NuGen Medical's time-series forecasting models are one of many NuGen Medical's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NuGen Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.NuGen Medical Devices Debt to Cash Allocation
Many companies such as NuGen Medical, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
NuGen Medical Devices has accumulated 5.61 M in total debt with debt to equity ratio (D/E) of 7.4, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. NuGen Medical Devices has a current ratio of 0.44, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist NuGen Medical until it has trouble settling it off, either with new capital or with free cash flow. So, NuGen Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NuGen Medical Devices sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NuGen to invest in growth at high rates of return. When we think about NuGen Medical's use of debt, we should always consider it together with cash and equity.NuGen Medical Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the NuGen Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of NuGen Medical, which in turn will lower the firm's financial flexibility.About NuGen OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how NuGen Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NuGen shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as NuGen Medical. By using and applying NuGen OTC Stock analysis, traders can create a robust methodology for identifying NuGen entry and exit points for their positions.
NuGen Medical Devices Inc., a specialty medical device company, focuses on developing and commercializing novel drug delivery technologies. It offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including anaphylaxis, diabetes, severe migraine, erectile dysfunction, chronic anemia, neutropenia, autoimmune rheumatoid arthritis, growth and fertility hormone, and psoriasis, as well as DNA and conventionalpediatric vaccines. Nugen Med operates under Medical Devices classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding NuGen Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Complementary Tools for NuGen OTC Stock analysis
When running NuGen Medical's price analysis, check to measure NuGen Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NuGen Medical is operating at the current time. Most of NuGen Medical's value examination focuses on studying past and present price action to predict the probability of NuGen Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NuGen Medical's price. Additionally, you may evaluate how the addition of NuGen Medical to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |